BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization

Research output: Contribution to journalArticle (Academic Journal)peer-review

49 Citations (Scopus)
520 Downloads (Pure)



The aim of this study was to obtain estimates of the causal relationship between BMI and mortality.


Mendelian randomization (MR) with BMI‐associated genotypic variation was used to test the causal effect of BMI on all‐cause and cause‐specific mortality in UK Biobank participants of White British ancestry.


MR analyses supported a causal association between higher BMI and greater risk of all‐cause mortality (hazard ratio [HR] per 1 kg/m2: 1.03; 95% CI: 0.99‐1.07) and mortality from cardiovascular diseases (HR: 1.10; 95% CI: 1.01‐1.19), specifically coronary heart disease (HR: 1.12; 95% CI: 1.00‐1.25) and those excluding coronary heart disease/stroke/aortic aneurysm (HR: 1.24; 95% CI: 1.03‐1.48), stomach cancer (HR: 1.18; 95% CI: 0.87‐1.62), and esophageal cancer (HR: 1.22; 95% CI: 0.98‐1.53), and a decreased risk of lung cancer mortality (HR: 0.96; 95% CI: 0.85‐1.08). Sex stratification supported the causal role of higher BMI increasing bladder cancer mortality risk (males) but decreasing respiratory disease mortality risk (males). The J‐shaped observational association between BMI and mortality was visible with MR analyses, but the BMI at which mortality was minimized was lower and the association was flatter over a larger BMI range.


Results support a causal role of higher BMI in increasing the risk of all‐cause mortality and mortality from several specific causes.
Original languageEnglish
Pages (from-to)1796-1806
Number of pages11
Issue number11
Early online date25 Oct 2018
Publication statusPublished - Nov 2018

Structured keywords

  • ICEP


Dive into the research topics of 'BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization'. Together they form a unique fingerprint.

Cite this